Literature DB >> 15918053

[Pulmonary hypertension: pathophysiology, genetics and functional genomics].

O Eickelberg1, W Seeger.   

Abstract

Novel discoveries of the genetic basis of pulmonary hypertension have recently inspired a whole new area of research in pulmonary medicine. The finding that germ-line mutations in the BMPR2 locus, encoding a transmembrane receptor of the TGF beta superfamily, are the cause for familial and partly idiopathic pulmonary arterial hypertension has provided new clues for our understanding of this complex, yet highly localized disease. The TGF beta superfamily comprises more than 40 different growth and differentiation factors essential in the control of proliferation and differentiation of most cell types. In this review, we summarize the novel genetic and functional genomic findings to provide an outlook for the understanding of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15918053     DOI: 10.1007/s00108-005-1431-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  40 in total

1.  Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance.

Authors:  D T DRESDALE; R J MICHTOM; M SCHULTZ
Journal:  Bull N Y Acad Med       Date:  1954-03

Review 2.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

3.  Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.

Authors:  Carl Atkinson; Susan Stewart; Paul D Upton; Rajiv Machado; Jennifer R Thomson; Richard C Trembath; Nicholas W Morrell
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

Review 4.  Primary pulmonary hypertension.

Authors:  S P Gaine; L J Rubin
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

5.  Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.

Authors:  Ayako Nishihara; Tetsuro Watabe; Takeshi Imamura; Kohei Miyazono
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

6.  Familial primary pulmonary hypertension: clinical patterns.

Authors:  J E Loyd; R K Primm; J H Newman
Journal:  Am Rev Respir Dis       Date:  1984-01

Review 7.  Genetic basis of pulmonary arterial hypertension: current understanding and future directions.

Authors:  John H Newman; Richard C Trembath; Jane A Morse; Ekkehard Grunig; James E Loyd; Serge Adnot; Fabio Coccolo; Carlo Ventura; John A Phillips; James A Knowles; Bart Janssen; Oliver Eickelberg; Saadia Eddahibi; Phillipe Herve; William C Nichols; Gregory Elliott
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

Review 8.  New insights into TGF-beta-Smad signalling.

Authors:  Peter ten Dijke; Caroline S Hill
Journal:  Trends Biochem Sci       Date:  2004-05       Impact factor: 13.807

9.  Inhaled iloprost for severe pulmonary hypertension.

Authors:  Horst Olschewski; Gerald Simonneau; Nazzareno Galiè; Timothy Higenbottam; Robert Naeije; Lewis J Rubin; Sylvia Nikkho; Rudolf Speich; Marius M Hoeper; Jürgen Behr; Jörg Winkler; Olivier Sitbon; Wladimir Popov; H Ardeschir Ghofrani; Alessandra Manes; David G Kiely; Ralph Ewert; Andreas Meyer; Paul A Corris; Marion Delcroix; Miguel Gomez-Sanchez; Harald Siedentop; Werner Seeger
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

10.  Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1.

Authors:  Victoria C Foletta; Mei Ann Lim; Juliana Soosairajah; April P Kelly; Edouard G Stanley; Mark Shannon; Wei He; Supratik Das; Joan Massague; Ora Bernard; Juliana Soosairaiah
Journal:  J Cell Biol       Date:  2003-09-08       Impact factor: 10.539

View more
  2 in total

1.  [Pulmonary arterial hypertension].

Authors:  F Reichenberger; R Voswinckel
Journal:  Internist (Berl)       Date:  2011-04       Impact factor: 0.743

2.  Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping.

Authors:  Michael Götting; Mario Schwarzer; Alexander Gerber; Doris Klingelhöfer; David A Groneberg
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.